Mosaad Megahed

5.1k total citations
177 papers, 3.1k citations indexed

About

Mosaad Megahed is a scholar working on Dermatology, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, Mosaad Megahed has authored 177 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Dermatology, 43 papers in Pathology and Forensic Medicine and 42 papers in Rheumatology. Recurrent topics in Mosaad Megahed's work include Autoimmune Bullous Skin Diseases (29 papers), Cancer and Skin Lesions (19 papers) and Urticaria and Related Conditions (18 papers). Mosaad Megahed is often cited by papers focused on Autoimmune Bullous Skin Diseases (29 papers), Cancer and Skin Lesions (19 papers) and Urticaria and Related Conditions (18 papers). Mosaad Megahed collaborates with scholars based in Germany, United States and France. Mosaad Megahed's co-authors include Thomas Ruzicka, Annegret Kuhn, Percy Lehmann, J. Reifenberger, Guido Reifenberger, Marietta Wolter, Monika Sonntag, Dagmar Richter-Hintz, Ruthild G. Weber and Peter Lichter and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Neurology.

In The Last Decade

Mosaad Megahed

163 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mosaad Megahed Germany	31	833	752	723	670	620	177	3.1k
Hiroshi Shinkai Japan	37	1.1k 1.3×	507 0.7×	586 0.8×	807 1.2×	839 1.4×	153	4.1k
Richard Groves United Kingdom	37	837 1.0×	681 0.9×	1.2k 1.7×	773 1.2×	1.6k 2.6×	99	4.3k
Astrid Jüngel Switzerland	37	2.1k 2.5×	876 1.2×	453 0.6×	1.1k 1.7×	1.1k 1.8×	67	4.6k
Rei Watanabe Japan	32	449 0.5×	482 0.6×	1.4k 2.0×	941 1.4×	2.2k 3.5×	123	4.1k
Thomas Hunziker Switzerland	30	427 0.5×	1.3k 1.8×	954 1.3×	1.4k 2.2×	585 0.9×	105	4.1k
Hidetoshi Okabe Japan	31	992 1.2×	452 0.6×	230 0.3×	360 0.5×	220 0.4×	217	3.2k
Shadmehr Demehri United States	29	868 1.0×	298 0.4×	827 1.1×	129 0.2×	927 1.5×	92	3.2k
George P. Stricklin United States	26	559 0.7×	290 0.4×	472 0.7×	192 0.3×	190 0.3×	44	2.4k
François‐Xavier Maquart France	36	1.1k 1.4×	201 0.3×	263 0.4×	202 0.3×	246 0.4×	104	3.2k
Yumin Xia China	29	717 0.9×	530 0.7×	264 0.4×	202 0.3×	807 1.3×	98	2.3k

Countries citing papers authored by Mosaad Megahed

Since Specialization

Citations

This map shows the geographic impact of Mosaad Megahed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mosaad Megahed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mosaad Megahed more than expected).

Fields of papers citing papers by Mosaad Megahed

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mosaad Megahed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mosaad Megahed. The network helps show where Mosaad Megahed may publish in the future.

Co-authorship network of co-authors of Mosaad Megahed

This figure shows the co-authorship network connecting the top 25 collaborators of Mosaad Megahed. A scholar is included among the top collaborators of Mosaad Megahed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mosaad Megahed. Mosaad Megahed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brodell, Robert T., Naji Kharouf, Thomas W. Flanagan, et al.. (2024). Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells. Cancers. 16(2). 470–470. 23 indexed citations

Selimović, Denis, Naji Kharouf, Florence Carrouel, et al.. (2023). Induction of Antimicrobial Protein S100A15 Expression by Oral Microbial Pathogens Is Toll-like Receptors-Dependent Activation of c-Jun-N-Terminal Kinase (JNK), p38, and NF-κB Pathways. International Journal of Molecular Sciences. 24(6). 5348–5348. 2 indexed citations

Kharouf, Naji, Thomas W. Flanagan, Mosaad Megahed, et al.. (2023). Tumor Microenvironment as a Therapeutic Target in Melanoma Treatment. Cancers. 15(12). 3147–3147. 18 indexed citations

Gündüz, Oğuzhan, et al.. (2022). Dual Spinneret Electrospun Polyurethane/PVA-Gelatin Nanofibrous Scaffolds Containing Cinnamon Essential Oil and Nanoceria for Chronic Diabetic Wound Healing: Preparation, Physicochemical Characterization and In-Vitro Evaluation. Molecules. 27(7). 2146–2146. 35 indexed citations

Ulağ, Songül, Ahmed S. Abo Dena, Ali Şahin, et al.. (2021). Chitosan/Gold Hybrid Nanoparticles Enriched Electrospun PVA Nanofibrous Mats for the Topical Delivery of Punica granatum L. Extract: Synthesis, Characterization, Biocompatibility and Antibacterial Properties. International Journal of Nanomedicine. Volume 16. 5133–5151. 35 indexed citations

Balakirski, Galina, Asem Alkhateeb, Hans F. Merk, M. Leverkus, & Mosaad Megahed. (2016). Successful treatment of bullous pemphigoid with omalizumab as corticosteroid‐sparing agent: report of two cases and review of literature. Journal of the European Academy of Dermatology and Venereology. 30(10). 1778–1782. 51 indexed citations

Jamal, Siraj M. El, et al.. (2016). Cancer stem cell as therapeutic target for melanoma treatment.. PubMed. 31(12). 1291–301. 13 indexed citations

Balakirski, Galina, M. Leverkus, Mosaad Megahed, & Hans F. Merk. (2015). Omalizumab-Treatment of therapy resistant bullous Pemphigoid. RWTH Publications (RWTH Aachen). 2 indexed citations

Wahl, R.U., et al.. (2014). [Atypical fibroxanthoma of the scalp: overview and recent developments].. Der Hautarzt. 65(12). 1008–1010. 2 indexed citations

10.

Gollnick, Harald, Carlos Guillén Barona, Thomas Ruzicka, et al.. (2009). Recurrence rate of superficial basal cell carcinoma following treatment with imiquimod 5% cream: conclusion of a 5-year long-term follow-up study in Europe.. PubMed. 18(6). 677–82. 81 indexed citations

11.

Megahed, Mosaad, et al.. (2007). 18. Aachener Dermatologenabend. Der Hautarzt. 58(11).

12.

Gollnick, Harald, Carlos Guillén Barona, Thomas Ruzicka, et al.. (2006). Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in Europe.. PubMed. 15(5). 374–81. 55 indexed citations

13.

Megahed, Mosaad, et al.. (2006). Dermatohistologisches Labor. Der Hautarzt. 57(9). 792–800. 3 indexed citations

14.

Sonntag, Monika, Percy Lehmann, Mosaad Megahed, Thomas Ruzicka, & Annegret Kuhn. (2003). Lupus erythematosus tumidus in Childhood. Dermatology. 207(2). 188–192. 24 indexed citations

15.

Lang, Karl S., J. Reifenberger, Thomas Ruzicka, & Mosaad Megahed. (2002). Type 1 segmental cutaneous leiomyomatosis. Clinical and Experimental Dermatology. 27(8). 649–650. 12 indexed citations

16.

Megahed, Mosaad, S. von Schmiedeberg, Jürgen Becker, & Thomas Ruzicka. (2001). Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent. Journal of the American Academy of Dermatology. 45(2). 256–259. 51 indexed citations

17.

Megahed, Mosaad, et al.. (1994). Angioimmunoblastic lymphadenopathy mimicking dermatitis herpetiformis (Duhring's disease). Der Hautarzt. 3 indexed citations

18.

Hofmann, U., et al.. (1992). [Grouped and combined blue nevi].. PubMed. 43(8). 517–9. 5 indexed citations

19.

Megahed, Mosaad, et al.. (1991). Lineare IgA-dermatose des Kindesalters. Monatsschrift Kinderheilkunde. 139(9). 636–638.

20.

Megahed, Mosaad, G. Goerz, P Kind, & Gerd Plewig. (1991). Pemphigus erythematosus with Suprabasilar Acantholysis and Lichenoid Tissue Reaction or a Combination of Pemphigus vulgaris and Lupus erythematosus: A New Entity?. Dermatology. 183(3). 216–217. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact